|
Volumn 12, Issue 5, 2006, Pages 300-305
|
Long-term lamotrigine plus lithium for bipolar disorder: One year outcome
|
Author keywords
Bipolar disorder; Combination treatment; Depression; Drug therapy; Lamotrigine; Lithium; Mania; Mood disorders; Polypharmacy; Prophylaxis
|
Indexed keywords
AMFEBUTAMONE;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
CLONAZEPAM;
ETIRACETAM;
FLUOXETINE;
GABAPENTIN;
LAMOTRIGINE;
LEVOTHYROXINE;
LITHIUM;
METHYLPHENIDATE;
NEUROLEPTIC AGENT;
OXCARBAZEPINE;
PAROXETINE;
QUETIAPINE;
RISPERIDONE;
SERTRALINE;
THYROID HORMONE;
TOPIRAMATE;
VALPROIC ACID;
ZIPRASIDONE;
ADULT;
AGED;
BIPOLAR DISORDER;
CLINICAL ARTICLE;
CLINICAL GLOBAL IMPRESSION SCALE;
COGNITION;
COGNITIVE DEFECT;
CONSTIPATION;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFICACY;
DRUG RESISTANCE;
FEMALE;
HUMAN;
LONG TERM CARE;
MALE;
MANIA;
MEMORY DISORDER;
MOOD DISORDER;
OBSERVATIONAL METHOD;
RASH;
RETROSPECTIVE STUDY;
REVIEW;
SEDATION;
SIDE EFFECT;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
TREATMENT WITHDRAWAL;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
DEPRESSION;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LITHIUM CARBONATE;
MALE;
MIDDLE AGED;
QUESTIONNAIRES;
RETROSPECTIVE STUDIES;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
TRIAZINES;
|
EID: 33748965779
PISSN: 15274160
EISSN: None
Source Type: Journal
DOI: 10.1097/00131746-200609000-00004 Document Type: Review |
Times cited : (9)
|
References (6)
|